Neurologic assessment in neuro-oncology (NANO) scale in a phase II study of pembrolizumab or pembrolizumab plus bevacizumab in patients with recurrent glioblastoma Meeting Abstract
| Authors: | Nayak, L.; Molinaro, A.; Peters, K.; Clarke, J.; Jordan, J.; de Groot, J.; Nghiemphu, P.; Kaley, T.; Colman, H.; McCluskey, C.; Gaffey, S.; Smith, T.; Cote, D.; Severgnini, M.; Yearley, J.; Zhao, Q.; Blumenschein, W.; Duda, G.; Muzikansky, A.; Jain, R.; Wen, P.; Reardon, D. |
| Abstract Title: | Neurologic assessment in neuro-oncology (NANO) scale in a phase II study of pembrolizumab or pembrolizumab plus bevacizumab in patients with recurrent glioblastoma |
| Meeting Title: | 25th Virtual Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology |
| Journal Title: | Neuro-Oncology |
| Volume: | 22 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2020 Nov 19-21 |
| Meeting Location: | Virtual |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-11-01 |
| Start Page: | ii138 |
| End Page: | ii139 |
| Language: | English |
| ACCESSION: | WOS:000590061300583 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/noaa215.582 |
| Notes: | Meeting Abstract: NCOG-44 -- Source: Wos |
